Loading stock analysis…
Evidence Synthesis
Last synthesized: 20 Oct 2026, 10:38
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
TITANBIO Sees Accelerating Shifts in Key Metrics, Driven by Strong Gross Margin Expansion and Increasing Daily Trading Volume.
Gross margin accelerated to , up from 18.8%.
The company also witnessed a notable increase in daily trading volume, with the metric moving from to .
Additionally, the close price accelerated to .45 INR, up from 406.9 INR.
These positive trends indicate a strengthening position for TITANBIO in the market.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 54.25 % | 18.8 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 18.8 % | 15.48 | ▲ |
| REVENUE_GROWTH_YOY | 27.3 % | 58.4 | ▼ |
| PRICE_CHANGE_PERCENT | 0.381 % | — | - |
| DAILY_VOLUME | 33,214 shares | 21,343 | ▲ |
| CLOSE_PRICE | 408.45 INR | 406.9 | ▲ |
Cite this
Source: Samhati evidence synthesis for TITANBIO (2026-10-20). Observation: TITANBIO Sees Accelerating Shifts in Key Metrics, Driven by Strong Gross Margin Expansion and Increasing Daily Trading Volume. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/titanbio
Filing step-changes